Biohaven's migraine drug research led to an FDA-approved product with strong commercial uptake, but its other neuroscience efforts have yet to achieve the same outcomes. Drug candidate troriluzole has failed a Phase 3 test in neuromuscular disorder spinocerebellar ataxia, the molecule's third failure in a pivotal study in the past two years.
In this free webinar on June 9th, industry experts from Syneos and Medable will share their perspectives on how to address these drug development challenges within cardiometabolic clinical studies and provide input on the impact of new regulatory guidance such as the DEPICT Act. This engaging panel will discuss leveraging technology and home health solutions to augment existing points of care between patients and their clinical care team to improve the patient experience, drive more scientific rigor to data generation and achieve timely endpoint capture.
By leveraging aligned interoperability partners, health systems can alleviate the inevitable pressures of IT personnel shortages and the strains that labor fluctuation puts on organizational technology transformation and growth.
The startup's Cordella Pulmonary Artery Pressure Sensor System, which was implanted in 70 heart failure patients in Europe, led to low hospitalization rates and high patient compliance with daily measurements needed to monitor them remotely.
Entasis Therapeutics is being acquired by Innoviva in a deal that brings an FDA-ready antibiotic developed to address drug-resistant strains of a bacterium that infects critically ill, immunocompromised patients. Innoviva has been steadily building up its stake in Entasis, an AstraZeneca spinout, over the past two years.
MedCity News is inviting all startups aiming to reinvent the clinical trials industry to apply to take part in the pitch contest during INVEST PharmaTechon July 26.
Startups in this category are developing products – both technology and services – that can help transform in-person, site-based clinical trials into purely clinical trials or incorporate additional digital elements to traditional clinical trial processes.
The contest is open to any startup founded in 2020 and earlier.
Application deadline is 5 ET, May 31.
MedCity News 611 Broadway New York, NY 10012 United States
You received this email because you are subscribed to MedCity Daily Digest from MedCity News.
Update your email preferences to choose the types of emails you receive.
No comments